Altre lingue Guilin Sanjin Pharmaceutical Co., Ltd.

Azioni

002275

CNE100000DY9

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
13,81 ^CNY	-8,42%		-9,44%	-4,69%

26/04	Guilin Sanjin Pharmaceutical Co., Ltd. propone il dividendo finale per il 2023	CI
25/04	Guilin Sanjin Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Guilin Sanjin Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023	26/04
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
Guilin Sanjin Pharma to Sell Land, Buildings For 111 Million Yuan	28/12
Guilin Sanjin Pharmaceutical Co., Ltd. Implements Profit Distribution plan for the Third Quarter of 2023, Payable on 27 November 2023	21/11
Guilin Sanjin Pharmaceutical Co., Ltd. Approves 2023 Third Quarter Profit Distribution Plan	15/11
Guilin Sanjin Pharmaceutical Co., Ltd. Proposes Third Quarter Dividend for 2023	30/10/23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Guilin Sanjin Pharmaceutical Co., Ltd.(XSEC:002275) added to S&P Global BMI Index	18/09/23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Guilin Sanjin Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023	24/05/23
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022	22/05/23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Board Elections	27/12/22
Guilin Sanjin Pharmaceutical Co., Ltd. Approves Dividend for the Third Quarter of 2022	15/11/22
Guilin Sanjin Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for the Third Quarter of 2022	31/10/22
Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Biocytogen Pharmaceuticals Raises $60 Million in RemeGen-Backed Hong Kong IPO	31/08/22
Biocytogen Pharmaceuticals Launches $70 Million Hong Kong IPO	19/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guilin Sanjin Pharmaceutical Co., Ltd.

Azioni

002275

CNE100000DY9

Altre lingue

Filtri